{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:00:58Z","timestamp":1793412058951,"version":"4.5.0"},"reference-count":141,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Immunol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1038\/s41590-026-02538-y","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T15:02:17Z","timestamp":1782745337000},"page":"1375-1389","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Adaptive immunity in the pathogenesis of neurodegeneration"],"prefix":"10.1038","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-1001-3095","authenticated-orcid":false,"given":"Yongyi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason D.","family":"Ulrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3400-0856","authenticated-orcid":false,"given":"David M.","family":"Holtzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"2538_CR1","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","volume":"179","author":"JM Long","year":"2019","unstructured":"Long, J. M. & Holtzman, D. M. Alzheimer disease: an update on pathobiology and treatment strategies. Cell 179, 312\u2013339 (2019).","journal-title":"Cell"},{"key":"2538_CR2","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1136\/jnnp-2019-322338","volume":"91","author":"J Jankovic","year":"2020","unstructured":"Jankovic, J. & Tan, E. K. Parkinson\u2019s disease: etiopathogenesis and treatment. J. Neurol. Neurosurg. Psychiatry 91, 795\u2013808 (2020).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"2538_CR3","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/S0140-6736(10)61156-7","volume":"377","author":"MC Kiernan","year":"2011","unstructured":"Kiernan, M. C. et al. Amyotrophic lateral sclerosis. Lancet 377, 942\u2013955 (2011).","journal-title":"Lancet"},{"key":"2538_CR4","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1016\/S0140-6736(00)04904-7","volume":"357","author":"J Parkin","year":"2001","unstructured":"Parkin, J. & Cohen, B. An overview of the immune system. Lancet 357, 1777\u20131789 (2001).","journal-title":"Lancet"},{"key":"2538_CR5","first-page":"58","volume":"29","author":"PB Medawar","year":"1948","unstructured":"Medawar, P. B. Immunity to homologous grafted skin. III. The fate of skin homographs transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. Br. J. Exp. Pathol. 29, 58\u201369 (1948).","journal-title":"Br. J. Exp. Pathol."},{"key":"2538_CR6","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1146\/annurev-physiol-022516-034406","volume":"79","author":"SA Wolf","year":"2017","unstructured":"Wolf, S. A., Boddeke, H. W. G. M. & Kettenmann, H. Microglia in physiology and disease. Annu. Rev. Physiol. 79, 619\u2013643 (2017).","journal-title":"Annu. Rev. Physiol."},{"key":"2538_CR7","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1126\/science.1110647","volume":"308","author":"A Nimmerjahn","year":"2005","unstructured":"Nimmerjahn, A., Kirchhoff, F. & Helmchen, F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308, 1314\u20131318 (2005).","journal-title":"Science"},{"key":"2538_CR8","doi-asserted-by":"publisher","first-page":"3974","DOI":"10.1523\/JNEUROSCI.4363-08.2009","volume":"29","author":"H Wake","year":"2009","unstructured":"Wake, H., Moorhouse, A. J., Jinno, S., Kohsaka, S. & Nabekura, J. Resting microglia directly monitor the functional state of synapses in vivo and determine the fate of ischemic terminals. J. Neurosci. 29, 3974\u20133980 (2009).","journal-title":"J. Neurosci."},{"key":"2538_CR9","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.immuni.2018.01.011","volume":"48","author":"D Mrdjen","year":"2018","unstructured":"Mrdjen, D. et al. High-dimensional single-cell mapping of central nervous system immune cells reveals distinct myeloid subsets in health, aging, and disease. Immunity 48, 380\u2013395.e6 (2018).","journal-title":"Immunity"},{"key":"2538_CR10","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.cell.2020.06.026","volume":"182","author":"E Pasciuto","year":"2020","unstructured":"Pasciuto, E. et al. Microglia require CD4 T cells to complete the fetal-to-adult transition. Cell 182, 625\u2013640.e24 (2020).","journal-title":"Cell"},{"key":"2538_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07053-9","volume":"9","author":"J Smolders","year":"2018","unstructured":"Smolders, J. et al. Tissue-resident memory T cells populate the human brain. Nat. Commun. 9, 4593 (2018).","journal-title":"Nat. Commun."},{"key":"2538_CR12","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.cell.2020.12.040","volume":"184","author":"J Rustenhoven","year":"2021","unstructured":"Rustenhoven, J. et al. Functional characterization of the dural sinuses as a neuroimmune interface. Cell 184, 1000\u20131016.e27 (2021). This study highlights the role of the dura mater as a critical neuroimmune interface, where CNS-derived antigens can be presented to circulating immune cells, allowing for immunosurveillance of the CNS.","journal-title":"Cell"},{"key":"2538_CR13","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.1093\/brain\/awt259","volume":"136","author":"G Kunis","year":"2013","unstructured":"Kunis, G. et al. IFN-\u03b3-dependent activation of the brain\u2019s choroid plexus for CNS immune surveillance and repair. Brain 136, 3427\u20133440 (2013).","journal-title":"Brain"},{"key":"2538_CR14","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/ni.3423","volume":"17","author":"T Goldmann","year":"2016","unstructured":"Goldmann, T. et al. Origin, fate and dynamics of macrophages at central nervous system interfaces. Nat. Immunol. 17, 797\u2013805 (2016).","journal-title":"Nat. Immunol."},{"key":"2538_CR15","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s41586-022-05474-7","volume":"612","author":"J Rustenhoven","year":"2022","unstructured":"Rustenhoven, J. & Kipnis, J. Brain borders at the central stage of neuroimmunology. Nature 612, 417\u2013429 (2022).","journal-title":"Nature"},{"key":"2538_CR16","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1038\/s41593-018-0227-9","volume":"21","author":"A Louveau","year":"2018","unstructured":"Louveau, A. et al. CNS lymphatic drainage and neuroinflammation are regulated by meningeal lymphatic vasculature. Nat. Neurosci. 21, 1380\u20131391 (2018).","journal-title":"Nat. Neurosci."},{"key":"2538_CR17","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1084\/jem.20142290","volume":"212","author":"A Aspelund","year":"2015","unstructured":"Aspelund, A. et al. A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules. J. Exp. Med. 212, 991\u2013999 (2015).","journal-title":"J. Exp. Med."},{"key":"2538_CR18","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature14432","volume":"523","author":"A Louveau","year":"2015","unstructured":"Louveau, A. et al. Structural and functional features of central nervous system lymphatic vessels. Nature 523, 337\u2013341 (2015).","journal-title":"Nature"},{"key":"2538_CR19","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.biopsych.2014.05.006","volume":"77","author":"CM Karch","year":"2015","unstructured":"Karch, C. M. & Goate, A. M. Alzheimer\u2019s disease risk genes and mechanisms of disease pathogenesis. Biol. Psychiatry 77, 43\u201351 (2015).","journal-title":"Biol. Psychiatry"},{"key":"2538_CR20","doi-asserted-by":"publisher","first-page":"3306","DOI":"10.1093\/brain\/awae177","volume":"147","author":"C Roodveldt","year":"2024","unstructured":"Roodveldt, C. et al. The immune system in Parkinson\u2019s disease: what we know so far. Brain 147, 3306\u20133324 (2024).","journal-title":"Brain"},{"key":"2538_CR21","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S1474-4422(18)30394-6","volume":"18","author":"DR Beers","year":"2019","unstructured":"Beers, D. R. & Appel, S. H. Immune dysregulation in amyotrophic lateral sclerosis: mechanisms and emerging therapies. Lancet Neurol. 18, 211\u2013220 (2019).","journal-title":"Lancet Neurol."},{"key":"2538_CR22","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/s41586-018-0543-y","volume":"562","author":"TJ Bussian","year":"2018","unstructured":"Bussian, T. J. et al. Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline. Nature 562, 578\u2013582 (2018).","journal-title":"Nature"},{"key":"2538_CR23","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/S0197-4580(88)80079-4","volume":"9","author":"J Rogers","year":"1988","unstructured":"Rogers, J., Luber-Narod, J., Styren, S. D. & Civin, W. H. Expression of immune system-associated antigens by cells of the human central nervous system: relationship to the pathology of Alzheimer\u2019s disease. Neurobiol. Aging 9, 339\u2013349 (1988).","journal-title":"Neurobiol. Aging"},{"key":"2538_CR24","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1001\/archneur.1993.00540010026013","volume":"50","author":"JI Engelhardt","year":"1993","unstructured":"Engelhardt, J. I., Tajti, J. & Appel, S. H. Lymphocytic infiltrates in the spinal cord in amyotrophic lateral sclerosis. Arch. Neurol. 50, 30\u201336 (1993).","journal-title":"Arch. Neurol."},{"key":"2538_CR25","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1002\/ana.410240415","volume":"24","author":"PL McGeer","year":"1988","unstructured":"McGeer, P. L., Itagaki, S., Akiyama, H. & McGeer, E. G. Rate of cell death in parkinsonism indicates active neuropathological process. Ann. Neurol. 24, 574\u2013576 (1988).","journal-title":"Ann. Neurol."},{"key":"2538_CR26","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1001\/archneur.1997.00550160085021","volume":"54","author":"P Bongioanni","year":"1997","unstructured":"Bongioanni, P., Boccardi, B., Borgna, M., Castagna, M. & Mondino, C. T-cell interferon gamma binding in patients with dementia of the Alzheimer type. Arch. Neurol. 54, 457\u2013462 (1997).","journal-title":"Arch. Neurol."},{"key":"2538_CR27","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1172\/JCI200318104","volume":"112","author":"A Monsonego","year":"2003","unstructured":"Monsonego, A. et al. Increased T cell reactivity to amyloid \u03b2 protein in older humans and patients with Alzheimer disease. J. Clin. Invest. 112, 415\u2013422 (2003).","journal-title":"J. Clin. Invest."},{"key":"2538_CR28","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.parkreldis.2005.07.005","volume":"11","author":"Y Baba","year":"2005","unstructured":"Baba, Y., Kuroiwa, A., Uitti, R. J., Wszolek, Z. K. & Yamada, T. Alterations of T-lymphocyte populations in Parkinson disease. Parkinsonism Relat. Disord. 11, 493\u2013498 (2005).","journal-title":"Parkinsonism Relat. Disord."},{"key":"2538_CR29","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.jneuroim.2006.10.001","volume":"182","author":"N Shi","year":"2007","unstructured":"Shi, N. et al. Increased IL-13-producing T cells in ALS: positive correlations with disease severity and progression rate. J. Neuroimmunol. 182, 232\u2013235 (2007).","journal-title":"J. Neuroimmunol."},{"key":"2538_CR30","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41586-019-1895-7","volume":"577","author":"D Gate","year":"2020","unstructured":"Gate, D. et al. Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer\u2019s disease. Nature 577, 399\u2013404 (2020). This study highlights clonal expansion of CD8+ T cells in the cerebrospinal fluid of patients with Alzheimer\u2019s disease, associated with worse cognition, and demonstrates the specificity and potential antigens of these clonally expanded T cells.","journal-title":"Nature"},{"key":"2538_CR31","doi-asserted-by":"publisher","first-page":"e0182002","DOI":"10.1371\/journal.pone.0182002","volume":"12","author":"MP Gustafson","year":"2017","unstructured":"Gustafson, M. P. et al. Comprehensive immune profiling reveals substantial immune system alterations in a subset of patients with amyotrophic lateral sclerosis. PLoS ONE 12, e0182002 (2017).","journal-title":"PLoS ONE"},{"key":"2538_CR32","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jneuroim.2009.02.012","volume":"210","author":"S Mantovani","year":"2009","unstructured":"Mantovani, S. et al. Immune system alterations in sporadic amyotrophic lateral sclerosis patients suggest an ongoing neuroinflammatory process. J. Neuroimmunol. 210, 73\u201379 (2009).","journal-title":"J. Neuroimmunol."},{"key":"2538_CR33","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jns.2014.09.025","volume":"347","author":"X Chen","year":"2014","unstructured":"Chen, X. et al. Evidence for peripheral immune activation in amyotrophic lateral sclerosis. J. Neurol. Sci. 347, 90\u201395 (2014).","journal-title":"J. Neurol. Sci."},{"key":"2538_CR34","doi-asserted-by":"publisher","first-page":"3130","DOI":"10.1016\/j.immuni.2025.10.025","volume":"58","author":"S Sureshchandra","year":"2025","unstructured":"Sureshchandra, S. et al. Deep profiling of human T cells defines compartmentalized clones and phenotypic trajectories across blood and tonsils. Immunity 58, 3130\u20133143.e8 (2025).","journal-title":"Immunity"},{"key":"2538_CR35","doi-asserted-by":"publisher","first-page":"5028","DOI":"10.1016\/j.cell.2022.11.019","volume":"185","author":"N Piehl","year":"2022","unstructured":"Piehl, N. et al. Cerebrospinal fluid immune dysregulation during healthy brain aging and cognitive impairment. Cell 185, 5028\u20135039.e13 (2022).","journal-title":"Cell"},{"key":"2538_CR36","doi-asserted-by":"publisher","first-page":"3364","DOI":"10.1093\/brain\/awaf167","volume":"148","author":"C Rickenbach","year":"2025","unstructured":"Rickenbach, C. et al. Altered T-cell reactivity in the early stages of Alzheimer\u2019s disease. Brain 148, 3364\u20133378 (2025).","journal-title":"Brain"},{"key":"2538_CR37","doi-asserted-by":"publisher","first-page":"S265","DOI":"10.3233\/JAD-230784","volume":"99","author":"Y Wang","year":"2024","unstructured":"Wang, Y. et al. Characteristics of T cells in single-cell datasets of peripheral blood and cerebrospinal fluid in Alzheimer\u2019s disease patients. J. Alzheimers Dis. 99, S265\u2013S280 (2024).","journal-title":"J. Alzheimers Dis."},{"key":"2538_CR38","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/s41586-022-04844-5","volume":"606","author":"L Campisi","year":"2022","unstructured":"Campisi, L. et al. Clonally expanded CD8 T cells characterize amyotrophic lateral sclerosis-4. Nature 606, 945\u2013952 (2022).","journal-title":"Nature"},{"key":"2538_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-62478-3","volume":"16","author":"M Ma","year":"2025","unstructured":"Ma, M. et al. The spatial landscape of glial pathology and T cell response in Parkinson\u2019s disease substantia nigra. Nat. Commun. 16, 7146 (2025).","journal-title":"Nat. Commun."},{"key":"2538_CR40","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/s41590-025-02401-6","volume":"27","author":"R Hobson","year":"2026","unstructured":"Hobson, R. et al. Clonal CD8+ T cells populate the leptomeninges and coordinate with immune cells in human degenerative brain diseases. Nat. Immunol. 27, 323\u2013335 (2026).","journal-title":"Nat. Immunol."},{"key":"2538_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33768-x","volume":"13","author":"G Li","year":"2022","unstructured":"Li, G. et al. TGF-\u03b2-dependent lymphoid tissue residency of stem-like T cells limits response to tumor vaccine. Nat. Commun. 13, 6043 (2022).","journal-title":"Nat. Commun."},{"key":"2538_CR42","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.immuni.2020.10.022","volume":"54","author":"T Hirai","year":"2021","unstructured":"Hirai, T. et al. Competition for active TGF\u03b2 cytokine allows for selective retention of antigen-specific tissue-resident memory T cells in the epidermal niche. Immunity 54, 84\u201398.e5 (2021).","journal-title":"Immunity"},{"key":"2538_CR43","doi-asserted-by":"crossref","unstructured":"Hayashi, F. et al. Antigen specificity of clonally enriched CD8+ T cells in multiple sclerosis. Nat. Immunol. 27, 490\u2013502 (2026).","DOI":"10.1038\/s41590-025-02412-3"},{"key":"2538_CR44","doi-asserted-by":"publisher","unstructured":"Chizari, S. et al. TDP-43 pathology induces CD8+ T cell activation through cryptic epitope recognition. Preprint at BioRxiv https:\/\/doi.org\/10.1101\/2025.06.22.660773 (2026).","DOI":"10.1101\/2025.06.22.660773"},{"key":"2538_CR45","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1159\/000486200","volume":"18","author":"M Merlini","year":"2018","unstructured":"Merlini, M., Kirabali, T., Kulic, L., Nitsch, R. M. & Ferretti, M. T. Extravascular CD3+ T cells in brains of Alzheimer disease patients correlate with tau but not with amyloid pathology: an immunohistochemical study. Neurodegener. Dis. 18, 49\u201356 (2018).","journal-title":"Neurodegener. Dis."},{"key":"2538_CR46","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/s41586-023-05788-0","volume":"615","author":"X Chen","year":"2023","unstructured":"Chen, X. et al. Microglia-mediated T cell infiltration drives neurodegeneration in tauopathy. Nature 615, 668\u2013677 (2023). This study provides direct evidence of how microglia\u2013T cell crosstalk can actively drive tau-mediated neurodegeneration in a mouse model of tauopathy.","journal-title":"Nature"},{"key":"2538_CR47","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1093\/brain\/awad309","volume":"147","author":"IJ Hartnell","year":"2024","unstructured":"Hartnell, I. J. et al. Glial reactivity and T cell infiltration in frontotemporal lobar degeneration with tau pathology. Brain 147, 590\u2013606 (2024).","journal-title":"Brain"},{"key":"2538_CR48","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.1093\/brain\/awaf135","volume":"148","author":"B Couto","year":"2025","unstructured":"Couto, B. et al. Midbrain cytotoxic T cells as a distinct neuropathological feature of progressive supranuclear palsy. Brain 148, 2650\u20132657 (2025).","journal-title":"Brain"},{"key":"2538_CR49","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1093\/brain\/aww270","volume":"140","author":"C Laurent","year":"2017","unstructured":"Laurent, C. et al. Hippocampal T cell infiltration promotes neuroinflammation and cognitive decline in a mouse model of tauopathy. Brain 140, 184\u2013200 (2017).","journal-title":"Brain"},{"key":"2538_CR50","first-page":"182","volume":"119","author":"V Brochard","year":"2008","unstructured":"Brochard, V. et al. Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. J. Clin. Invest. 119, 182\u2013192 (2008). This study demonstrates that ablation of CD4+, but not CD8+, T cells reduces neuronal loss in an MPTP-induced mouse model of Parkinson\u2019s disease, highlighting a deleterious role of CD4+ T cells in the pathogenesis of this disease.","journal-title":"J. Clin. Invest."},{"key":"2538_CR51","doi-asserted-by":"publisher","first-page":"3717","DOI":"10.1093\/brain\/awaa269","volume":"143","author":"J Galiano-Landeira","year":"2020","unstructured":"Galiano-Landeira, J., Torra, A., Vila, M. & Bov\u00e9, J. CD8 T cell nigral infiltration precedes synucleinopathy in early stages of Parkinson\u2019s disease. Brain 143, 3717\u20133733 (2020).","journal-title":"Brain"},{"key":"2538_CR52","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s40478-020-01083-5","volume":"8","author":"A Kouli","year":"2020","unstructured":"Kouli, A., Camacho, M., Allinson, K. & Williams-Gray, C. H. Neuroinflammation and protein pathology in Parkinson\u2019s disease dementia. Acta Neuropathol. Commun. 8, 211 (2020).","journal-title":"Acta Neuropathol. Commun."},{"key":"2538_CR53","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.bbi.2022.01.007","volume":"101","author":"AA Karikari","year":"2022","unstructured":"Karikari, A. A. et al. Neurodegeneration by \u03b1-synuclein-specific T cells in AAV-A53T-\u03b1-synuclein Parkinson\u2019s disease mice. Brain Behav. Immun. 101, 194\u2013210 (2022).","journal-title":"Brain Behav. Immun."},{"key":"2538_CR54","doi-asserted-by":"publisher","first-page":"fcab157","DOI":"10.1093\/braincomms\/fcab157","volume":"3","author":"L Rolfes","year":"2021","unstructured":"Rolfes, L. et al. Amyotrophic lateral sclerosis patients show increased peripheral and intrathecal T-cell activation. Brain Commun. 3, fcab157 (2021).","journal-title":"Brain Commun."},{"key":"2538_CR55","doi-asserted-by":"publisher","first-page":"15558","DOI":"10.1073\/pnas.0807419105","volume":"105","author":"DR Beers","year":"2008","unstructured":"Beers, D. R., Henkel, J. S., Zhao, W., Wang, J. & Appel, S. H. CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS. Proc. Natl Acad. Sci. USA 105, 15558\u201315563 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2538_CR56","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1073\/pnas.1815961116","volume":"116","author":"E Coque","year":"2019","unstructured":"Coque, E. et al. Cytotoxic CD8+ T lymphocytes expressing ALS-causing SOD1 mutant selectively trigger death of spinal motoneurons. Proc. Natl Acad. Sci. USA 116, 2312\u20132317 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2538_CR57","doi-asserted-by":"publisher","first-page":"17913","DOI":"10.1073\/pnas.0804610105","volume":"105","author":"IM Chiu","year":"2008","unstructured":"Chiu, I. M. et al. T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS. Proc. Natl Acad. Sci. USA 105, 17913\u201317918 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2538_CR58","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1038\/s41590-025-02198-4","volume":"26","author":"HD Mason","year":"2025","unstructured":"Mason, H. D. et al. Granzyme K+ CD8 T cells slow tauopathy progression by targeting microglia. Nat. Immunol. 26, 1152\u20131167 (2025).","journal-title":"Nat. Immunol."},{"key":"2538_CR59","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41577-024-01104-7","volume":"25","author":"MT Heneka","year":"2025","unstructured":"Heneka, M. T. et al. Neuroinflammation in Alzheimer disease. Nat. Rev. Immunol. 25, 321\u2013352 (2025).","journal-title":"Nat. Rev. Immunol."},{"key":"2538_CR60","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1038\/s41593-023-01415-3","volume":"26","author":"M Jorfi","year":"2023","unstructured":"Jorfi, M. et al. Infiltrating CD8+ T cells exacerbate Alzheimer\u2019s disease pathology in a 3D human neuroimmune axis model. Nat. Neurosci. 26, 1489\u20131504 (2023). The authors of this study developed a novel 3D human embryonic stem cell-derived triculture model to recapitulate the full neuropathological cascade of Alzheimer\u2019s disease and were able to demonstrate a crucial neuroimmune axis underlying T cell infiltration in Alzheimer\u2019s disease.","journal-title":"Nat. Neurosci."},{"key":"2538_CR61","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1038\/s41590-023-01604-z","volume":"24","author":"W Su","year":"2023","unstructured":"Su, W. et al. CXCR6 orchestrates brain CD8+ T cell residency and limits mouse Alzheimer\u2019s disease pathology. Nat. Immunol. 24, 1735\u20131747 (2023).","journal-title":"Nat. Immunol."},{"key":"2538_CR62","doi-asserted-by":"publisher","first-page":"102587","DOI":"10.1016\/j.pneurobio.2024.102587","volume":"235","author":"V La Cognata","year":"2024","unstructured":"La Cognata, V., Morello, G., Guarnaccia, M. & Cavallaro, S. The multifaceted role of the CXC chemokines and receptors signaling axes in ALS pathophysiology. Prog. Neurobiol. 235, 102587 (2024).","journal-title":"Prog. Neurobiol."},{"key":"2538_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-023-02723-y","volume":"20","author":"Y Xu","year":"2023","unstructured":"Xu, Y. et al. The reciprocal interactions between microglia and T cells in Parkinson\u2019s disease: a double-edged sword. J. Neuroinflammation 20, 33 (2023).","journal-title":"J. Neuroinflammation"},{"key":"2538_CR64","first-page":"925135","volume":"2012","author":"RV Luckheeram","year":"2012","unstructured":"Luckheeram, R. V., Zhou, R., Verma, A. D. & Xia, B. CD4+ T cells: differentiation and functions. J. Immunol. Res. 2012, 925135 (2012).","journal-title":"J. Immunol. Res."},{"key":"2538_CR65","doi-asserted-by":"publisher","first-page":"eabo7649","DOI":"10.1126\/science.abo7649","volume":"380","author":"G Castellani","year":"2023","unstructured":"Castellani, G., Croese, T., Peralta Ramos, J. M. & Schwartz, M. Transforming the understanding of brain immunity. Science 380, eabo7649 (2023).","journal-title":"Science"},{"key":"2538_CR66","doi-asserted-by":"publisher","first-page":"3979","DOI":"10.4049\/jimmunol.0801218","volume":"182","author":"SA Wolf","year":"2009","unstructured":"Wolf, S. A. et al. CD4-positive T lymphocytes provide a neuroimmunological link in the control of adult hippocampal neurogenesis. J. Immunol. 182, 3979\u20133984 (2009).","journal-title":"J. Immunol."},{"key":"2538_CR67","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1126\/science.abf7266","volume":"374","author":"D Gate","year":"2021","unstructured":"Gate, D. et al. CD4+ T cells contribute to neurodegeneration in Lewy body dementia. Science 374, 868\u2013874 (2021). In this study, clonally expanded CD4+ T cells in the brains of patients with Lewy body dementia were associated with neuronal loss and the chemokine\u2013receptor axis was identified as underlying T cell recruitment in this disease.","journal-title":"Science"},{"key":"2538_CR68","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-021-02308-7","volume":"18","author":"J Machhi","year":"2021","unstructured":"Machhi, J. et al. CD4+ effector T cells accelerate Alzheimer\u2019s disease in mice. J. Neuroinflammation 18, 272 (2021).","journal-title":"J. Neuroinflammation"},{"key":"2538_CR69","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.isci.2019.05.039","volume":"16","author":"K Mittal","year":"2019","unstructured":"Mittal, K. et al. CD4 T cells induce a subset of MHCII-expressing microglia that attenuates Alzheimer pathology. iScience 16, 298\u2013311 (2019).","journal-title":"iScience"},{"key":"2538_CR70","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41590-022-01387-9","volume":"24","author":"A Schnell","year":"2023","unstructured":"Schnell, A., Littman, D. R. & Kuchroo, V. K. TH17 cell heterogeneity and its role in tissue inflammation. Nat. Immunol. 24, 19\u201329 (2023).","journal-title":"Nat. Immunol."},{"key":"2538_CR71","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.4049\/jimmunol.0901852","volume":"184","author":"AD Reynolds","year":"2010","unstructured":"Reynolds, A. D. et al. Regulatory T cells attenuate TH17 cell-mediated nigrostriatal dopaminergic neurodegeneration in a model of Parkinson\u2019s disease. J. Immunol. 184, 2261\u20132271 (2010).","journal-title":"J. Immunol."},{"key":"2538_CR72","doi-asserted-by":"publisher","first-page":"7762","DOI":"10.1007\/s12035-016-0249-9","volume":"54","author":"Z Liu","year":"2017","unstructured":"Liu, Z., Huang, Y., Cao, B.-B., Qiu, Y.-H. & Peng, Y.-P. TH17 cells induce dopaminergic neuronal death via LFA-1\/ICAM-1 interaction in a mouse model of Parkinson\u2019s disease. Mol. Neurobiol. 54, 7762\u20137776 (2017).","journal-title":"Mol. Neurobiol."},{"key":"2538_CR73","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.bbi.2022.10.023","volume":"108","author":"J Li","year":"2023","unstructured":"Li, J. et al. \u03b1-Synuclein induces TH17 differentiation and impairs the function and stability of Tregs by promoting RORC transcription in Parkinson\u2019s disease. Brain Behav. Immun. 108, 32\u201344 (2023).","journal-title":"Brain Behav. Immun."},{"key":"2538_CR74","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.stem.2018.06.015","volume":"23","author":"A Sommer","year":"2018","unstructured":"Sommer, A. et al. TH17 lymphocytes induce neuronal cell death in a human iPSC-based model of Parkinson\u2019s disease. Cell Stem Cell 23, 123\u2013131.e6 (2018).","journal-title":"Cell Stem Cell"},{"key":"2538_CR75","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.clim.2013.04.010","volume":"148","author":"M Saresella","year":"2013","unstructured":"Saresella, M. et al. T helper-17 activation dominates the immunologic milieu of both amyotrophic lateral sclerosis and progressive multiple sclerosis. Clin. Immunol. 148, 79\u201388 (2013).","journal-title":"Clin. Immunol."},{"key":"2538_CR76","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-7-76","volume":"7","author":"M Fiala","year":"2010","unstructured":"Fiala, M. et al. IL-17A is increased in the serum and in spinal cord CD8 and mast cells of ALS patients. J. Neuroinflammation 7, 76 (2010).","journal-title":"J. Neuroinflammation"},{"key":"2538_CR77","doi-asserted-by":"publisher","first-page":"e1106","DOI":"10.1212\/NXI.0000000000001106","volume":"9","author":"C Joshi","year":"2022","unstructured":"Joshi, C. et al. CSF-derived CD4+ T-cell diversity is reduced in patients with Alzheimer clinical syndrome. Neurol. Neuroimmunol. Neuroinflamm. 9, e1106 (2022).","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"2538_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15626-w","volume":"11","author":"CS Lindestam Arlehamn","year":"2020","unstructured":"Lindestam Arlehamn, C. S. et al. \u03b1-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson\u2019s disease. Nat. Commun. 11, 1875 (2020).","journal-title":"Nat. Commun."},{"key":"2538_CR79","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-79726-9","volume":"11","author":"A Singhania","year":"2021","unstructured":"Singhania, A. et al. The TCR repertoire of \u03b1-synuclein-specific T cells in Parkinson\u2019s disease is surprisingly diverse. Sci. Rep. 11, 302 (2021).","journal-title":"Sci. Rep."},{"key":"2538_CR80","doi-asserted-by":"publisher","first-page":"e2302720120","DOI":"10.1073\/pnas.2302720120","volume":"120","author":"Y Le Guen","year":"2023","unstructured":"Le Guen, Y. et al. Multiancestry analysis of the HLA locus in Alzheimer\u2019s and Parkinson\u2019s diseases uncovers a shared adaptive immune response mediated by HLA-DRB1*04 subtypes. Proc. Natl Acad. Sci. USA 120, e2302720120 (2023).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2538_CR81","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/ng.642","volume":"42","author":"TH Hamza","year":"2010","unstructured":"Hamza, T. H. et al. Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson\u2019s disease. Nat. Genet. 42, 781\u2013785 (2010).","journal-title":"Nat. Genet."},{"key":"2538_CR82","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/S0165-5728(02)00219-9","volume":"130","author":"J Kipnis","year":"2002","unstructured":"Kipnis, J., Yoles, E., Mizrahi, T., Ben-Nur, A. & Schwartz, M. Myelin specific TH1 cells are necessary for post-traumatic protective autoimmunity. J. Neuroimmunology 130, 78\u201385 (2002).","journal-title":"J. Neuroimmunology"},{"key":"2538_CR83","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/4734","volume":"5","author":"G Moalem","year":"1999","unstructured":"Moalem, G. et al. Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat. Med. 5, 49\u201355 (1999).","journal-title":"Nat. Med."},{"key":"2538_CR84","doi-asserted-by":"publisher","first-page":"6421","DOI":"10.1523\/JNEUROSCI.20-17-06421.2000","volume":"20","author":"E Hauben","year":"2000","unstructured":"Hauben, E. et al. Passive or active immunization with myelin basic protein promotes recovery from spinal cord contusion. J. Neurosci. 20, 6421\u20136430 (2000).","journal-title":"J. Neurosci."},{"key":"2538_CR85","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.it.2024.08.002","volume":"45","author":"M Schwartz","year":"2024","unstructured":"Schwartz, M. & Colaiuta, S. P. Boosting peripheral immunity to fight neurodegeneration in the brain. Trends Immunol. 45, 760\u2013767 (2024).","journal-title":"Trends Immunol."},{"key":"2538_CR86","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nature22815","volume":"546","author":"D Sulzer","year":"2017","unstructured":"Sulzer, D. et al. T cells from patients with Parkinson\u2019s disease recognize \u03b1-synuclein peptides. Nature 546, 656\u2013661 (2017). This study identified \u03b1-synuclein-derived peptides as cognate antigens presented by specific HLA alleles, driving the autoreactive T cell response in patients with Parkinson\u2019s disease.","journal-title":"Nature"},{"key":"2538_CR87","doi-asserted-by":"publisher","first-page":"3397","DOI":"10.1016\/j.neuron.2023.07.015","volume":"111","author":"F Garretti","year":"2023","unstructured":"Garretti, F. et al. Interaction of an \u03b1-synuclein epitope with HLA-DRB1*15:01 triggers enteric features in mice reminiscent of prodromal Parkinson\u2019s disease. Neuron 111, 3397\u20133413.e5 (2023).","journal-title":"Neuron"},{"key":"2538_CR88","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41531-025-01001-3","volume":"11","author":"E Johansson","year":"2025","unstructured":"Johansson, E. et al. T cell responses towards PINK1 and \u03b1-synuclein are elevated in prodromal Parkinson\u2019s disease. NPJ Parkinsons Dis. 11, 137 (2025).","journal-title":"NPJ Parkinsons Dis."},{"key":"2538_CR89","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.neuron.2014.12.007","volume":"85","author":"AM Pickrell","year":"2015","unstructured":"Pickrell, A. M. & Youle, R. J. The roles of PINK1, parkin and mitochondrial fidelity in Parkinson\u2019s disease. Neuron 85, 257\u2013273 (2015).","journal-title":"Neuron"},{"key":"2538_CR90","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/s41586-025-09588-6","volume":"647","author":"T Michaelis","year":"2025","unstructured":"Michaelis, T. et al. Autoimmune response to C9orf72 protein in amyotrophic lateral sclerosis. Nature 647, 970\u2013978 (2025).","journal-title":"Nature"},{"key":"2538_CR91","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1007\/s12640-009-9076-3","volume":"16","author":"M Shimoji","year":"2009","unstructured":"Shimoji, M., Pagan, F., Healton, E. B. & Mocchetti, I. CXCR4 and CXCL12 expression is increased in the nigro-striatal system of Parkinson\u2019s disease. Neurotox. Res. 16, 318\u2013328 (2009).","journal-title":"Neurotox. Res"},{"key":"2538_CR92","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-020-01776-7","volume":"17","author":"J Rostami","year":"2020","unstructured":"Rostami, J. et al. Astrocytes have the capacity to act as antigen-presenting cells in the Parkinson\u2019s disease brain. J. Neuroinflammation 17, 119 (2020).","journal-title":"J. Neuroinflammation"},{"key":"2538_CR93","doi-asserted-by":"publisher","first-page":"e8784","DOI":"10.1371\/journal.pone.0008784","volume":"5","author":"V Sanchez-Guajardo","year":"2010","unstructured":"Sanchez-Guajardo, V., Febbraro, F., Kirik, D. & Romero-Ramos, M. Microglia acquire distinct activation profiles depending on the degree of \u03b1-synuclein neuropathology in a rAAV based model of Parkinson\u2019s disease. PLoS ONE 5, e8784 (2010).","journal-title":"PLoS ONE"},{"key":"2538_CR94","doi-asserted-by":"publisher","first-page":"9592","DOI":"10.1523\/JNEUROSCI.5610-12.2013","volume":"33","author":"AS Harms","year":"2013","unstructured":"Harms, A. S. et al. MHCII is required for \u03b1-synuclein-induced activation of microglia, CD4 T cell proliferation, and dopaminergic neurodegeneration. J. Neurosci. 33, 9592\u20139600 (2013).","journal-title":"J. Neurosci."},{"key":"2538_CR95","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1002\/glia.22935","volume":"64","author":"HL Martin","year":"2016","unstructured":"Martin, H. L. et al. Evidence for a role of adaptive immune response in the disease pathogenesis of the MPTP mouse model of Parkinson\u2019s disease. Glia 64, 386\u2013395 (2016).","journal-title":"Glia"},{"key":"2538_CR96","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s00401-021-02268-5","volume":"141","author":"AS Harms","year":"2021","unstructured":"Harms, A. S., Ferreira, S. A. & Romero-Ramos, M. Periphery and brain, innate and adaptive immunity in Parkinson\u2019s disease. Acta Neuropathol. 141, 527\u2013545 (2021).","journal-title":"Acta Neuropathol."},{"key":"2538_CR97","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s11481-015-9618-9","volume":"10","author":"H Gonz\u00e1lez","year":"2015","unstructured":"Gonz\u00e1lez, H., Contreras, F. & Pacheco, R. Regulation of the neurodegenerative process associated to Parkinson\u2019s disease by CD4+ T-cells. J. Neuroimmune Pharmacol. 10, 561\u2013575 (2015).","journal-title":"J. Neuroimmune Pharmacol."},{"key":"2538_CR98","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1158\/2159-8290.CD-18-0367","volume":"8","author":"SC Wei","year":"2018","unstructured":"Wei, S. C., Duffy, C. R. & Allison, J. P. Fundamental mechanisms of immune checkpoint blockade therapy. Cancer Discov. 8, 1069\u20131086 (2018).","journal-title":"Cancer Discov."},{"key":"2538_CR99","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/nm.4022","volume":"22","author":"K Baruch","year":"2016","unstructured":"Baruch, K. et al. PD-1 immune checkpoint blockade reduces pathology and improves memory in mouse models of Alzheimer\u2019s disease. Nat. Med. 22, 135\u2013137 (2016).","journal-title":"Nat. Med."},{"key":"2538_CR100","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08352-5","volume":"10","author":"N Rosenzweig","year":"2019","unstructured":"Rosenzweig, N. et al. PD-1\/PD-L1 checkpoint blockade harnesses monocyte-derived macrophages to combat cognitive impairment in a tauopathy mouse model. Nat. Commun. 10, 465 (2019).","journal-title":"Nat. Commun."},{"key":"2538_CR101","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8967","volume":"6","author":"K Baruch","year":"2015","unstructured":"Baruch, K. et al. Breaking immune tolerance by targeting Foxp3+ regulatory T cells mitigates Alzheimer\u2019s disease pathology. Nat. Commun. 6, 7967 (2015).","journal-title":"Nat. Commun."},{"key":"2538_CR102","doi-asserted-by":"publisher","first-page":"e89530","DOI":"10.1172\/jci.insight.89530","volume":"2","author":"DR Beers","year":"2017","unstructured":"Beers, D. R. et al. ALS patients\u2019 regulatory T lymphocytes are dysfunctional, and correlate with disease progression rate and severity. JCI Insight 2, e89530 (2017).","journal-title":"JCI Insight"},{"key":"2538_CR103","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1001\/jamaneurol.2018.0035","volume":"75","author":"RK Sheean","year":"2018","unstructured":"Sheean, R. K. et al. Association of regulatory T-cell expansion with progression of amyotrophic lateral sclerosis: a study of humans and a transgenic mouse model. JAMA Neurol. 75, 681\u2013689 (2018).","journal-title":"JAMA Neurol."},{"key":"2538_CR104","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1093\/brain\/awv408","volume":"139","author":"C Dansokho","year":"2016","unstructured":"Dansokho, C. et al. Regulatory T cells delay disease progression in Alzheimer-like pathology. Brain 139, 1237\u20131251 (2016).","journal-title":"Brain"},{"key":"2538_CR105","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34526-9","volume":"13","author":"S Yazdani","year":"2022","unstructured":"Yazdani, S. et al. T cell responses at diagnosis of amyotrophic lateral sclerosis predict disease progression. Nat. Commun. 13, 6733 (2022).","journal-title":"Nat. Commun."},{"key":"2538_CR106","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/emmm.201201544","volume":"5","author":"JS Henkel","year":"2013","unstructured":"Henkel, J. S. et al. Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival. EMBO Mol. Med. 5, 64\u201379 (2013).","journal-title":"EMBO Mol. Med."},{"key":"2538_CR107","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1093\/brain\/awr074","volume":"134","author":"DR Beers","year":"2011","unstructured":"Beers, D. R. et al. Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis. Brain 134, 1293\u20131314 (2011). Using a mouse model of ALS, this study demonstrates the neuroprotective role of Treg cells, mediated through interactions with microglia. The authors extend these findings to patients with ALS and establish a correlation between Treg cells and disease progression, supporting a rationale for Treg cell immunotherapy.","journal-title":"Brain"},{"key":"2538_CR108","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.nbd.2012.07.008","volume":"48","author":"W Zhao","year":"2012","unstructured":"Zhao, W., Beers, D. R., Liao, B., Henkel, J. S. & Appel, S. H. Regulatory T lymphocytes from ALS mice suppress microglia and effector T lymphocytes through different cytokine-mediated mechanisms. Neurobiol. Dis. 48, 418\u2013428 (2012).","journal-title":"Neurobiol. Dis."},{"key":"2538_CR109","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1097\/RLU.0000000000005955","volume":"50","author":"T Singhal","year":"2025","unstructured":"Singhal, T. et al. Dampening of microglial activation with nasal foralumab administration in moderate Alzheimer\u2019s disease dementia. Clin. Nucl. Med. 50, 756\u2013757 (2025).","journal-title":"Clin. Nucl. Med."},{"key":"2538_CR110","doi-asserted-by":"publisher","first-page":"EVIDoa2400249","DOI":"10.1056\/EVIDoa2400249","volume":"4","author":"NA Shneider","year":"2025","unstructured":"Shneider, N. A. et al. Clinical safety and preliminary efficacy of regulatory T cells for ALS. NEJM Evid. 4, EVIDoa2400249 (2025).","journal-title":"NEJM Evid."},{"key":"2538_CR111","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s41392-025-02326-4","volume":"10","author":"L Wang","year":"2025","unstructured":"Wang, L. et al. Regulatory T cells in homeostasis and disease: molecular mechanisms and therapeutic potential. Sig. Transduct. Target. Ther. 10, 345 (2025).","journal-title":"Sig. Transduct. Target. Ther."},{"key":"2538_CR112","doi-asserted-by":"publisher","first-page":"eadu2910","DOI":"10.1126\/sciimmunol.adu2910","volume":"10","author":"M Marin-Rodero","year":"2025","unstructured":"Marin-Rodero, M. et al. The meninges host a distinct compartment of regulatory T cells that preserves brain homeostasis. Sci. Immunol. 10, eadu2910 (2025).","journal-title":"Sci. Immunol."},{"key":"2538_CR113","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41577-021-00519-w","volume":"21","author":"AR Mu\u00f1oz-Rojas","year":"2021","unstructured":"Mu\u00f1oz-Rojas, A. R. & Mathis, D. Tissue regulatory T cells: regulatory chameleons. Nat. Rev. Immunol. 21, 597\u2013611 (2021).","journal-title":"Nat. Rev. Immunol."},{"key":"2538_CR114","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41577-023-00960-z","volume":"24","author":"A Liston","year":"2024","unstructured":"Liston, A., Pasciuto, E., Fitzgerald, D. C. & Yshii, L. Brain regulatory T cells. Nat. Rev. Immunol. 24, 326\u2013337 (2024).","journal-title":"Nat. Rev. Immunol."},{"key":"2538_CR115","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/s41586-018-0824-5","volume":"565","author":"M Ito","year":"2019","unstructured":"Ito, M. et al. Brain regulatory T cells suppress astrogliosis and potentiate neurological recovery. Nature 565, 246\u2013250 (2019).","journal-title":"Nature"},{"key":"2538_CR116","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1146\/annurev-immunol-041015-055605","volume":"34","author":"CG Vinuesa","year":"2016","unstructured":"Vinuesa, C. G., Linterman, M. A., Yu, D. & MacLennan, I. C. M. Follicular helper T cells. Annu. Rev. Immunol. 34, 335\u2013368 (2016).","journal-title":"Annu. Rev. Immunol."},{"key":"2538_CR117","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/ana.25927","volume":"89","author":"G Comi","year":"2021","unstructured":"Comi, G. et al. Role of B cells in multiple sclerosis and related disorders. Ann. Neurol. 89, 13\u201323 (2021).","journal-title":"Ann. Neurol."},{"key":"2538_CR118","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/s41577-021-00652-6","volume":"22","author":"RW Jain","year":"2022","unstructured":"Jain, R. W. & Yong, V. W. B cells in central nervous system disease: diversity, locations and pathophysiology. Nat. Rev. Immunol. 22, 513\u2013524 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"2538_CR119","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.3233\/JAD-161304","volume":"58","author":"M Busse","year":"2017","unstructured":"Busse, M. et al. Alterations in the peripheral immune system in dementia. J. Alzheimers Dis. 58, 1303\u20131313 (2017).","journal-title":"J. Alzheimers Dis."},{"key":"2538_CR120","doi-asserted-by":"publisher","first-page":"fcad060","DOI":"10.1093\/braincomms\/fcad060","volume":"5","author":"KM Scott","year":"2023","unstructured":"Scott, K. M. et al. B lymphocyte responses in Parkinson\u2019s disease and their possible significance in disease progression. Brain Commun. 5, fcad060 (2023).","journal-title":"Brain Commun."},{"key":"2538_CR121","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jneuroim.2009.07.011","volume":"215","author":"IA Saleh","year":"2009","unstructured":"Saleh, I. A. et al. Evaluation of humoral immune response in adaptive immunity in ALS patients during disease progression. J. Neuroimmunol. 215, 96\u2013101 (2009).","journal-title":"J. Neuroimmunol."},{"key":"2538_CR122","doi-asserted-by":"publisher","first-page":"17458","DOI":"10.1074\/jbc.M414176200","volume":"280","author":"RD Moir","year":"2005","unstructured":"Moir, R. D. et al. Autoantibodies to redox-modified oligomeric Abeta are attenuated in the plasma of Alzheimer\u2019s disease patients. J. Biol. Chem. 280, 17458\u201317463 (2005).","journal-title":"J. Biol. Chem."},{"key":"2538_CR123","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.jneuroim.2014.06.017","volume":"274","author":"B-X Qu","year":"2014","unstructured":"Qu, B.-X. et al. Beta-amyloid auto-antibodies are reduced in Alzheimer\u2019s disease. J. Neuroimmunol. 274, 168\u2013173 (2014).","journal-title":"J. Neuroimmunol."},{"key":"2538_CR124","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s00401-017-1705-y","volume":"133","author":"G Pascual","year":"2017","unstructured":"Pascual, G. et al. Immunological memory to hyperphosphorylated tau in asymptomatic individuals. Acta Neuropathol. 133, 767\u2013783 (2017).","journal-title":"Acta Neuropathol."},{"key":"2538_CR125","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s00401-019-01974-5","volume":"137","author":"X Li","year":"2019","unstructured":"Li, X. et al. Naturally occurring antibodies isolated from PD patients inhibit synuclein seeding in vitro and recognize Lewy pathology. Acta Neuropathol. 137, 825\u2013836 (2019).","journal-title":"Acta Neuropathol."},{"key":"2538_CR126","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.bbi.2022.11.012","volume":"108","author":"W Feng","year":"2023","unstructured":"Feng, W. et al. B lymphocytes ameliorate Alzheimer\u2019s disease-like neuropathology via interleukin-35. Brain Behav. Immun. 108, 16\u201331 (2023).","journal-title":"Brain Behav. Immun."},{"key":"2538_CR127","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22479-4","volume":"12","author":"K Kim","year":"2021","unstructured":"Kim, K. et al. Therapeutic B-cell depletion reverses progression of Alzheimer\u2019s disease. Nat. Commun. 12, 2185 (2021).","journal-title":"Nat. Commun."},{"key":"2538_CR128","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1093\/brain\/awab103","volume":"144","author":"GP Williams","year":"2021","unstructured":"Williams, G. P. et al. CD4 T cells mediate brain inflammation and neurodegeneration in a mouse model of Parkinson\u2019s disease. Brain 144, 2047\u20132059 (2021).","journal-title":"Brain"},{"key":"2538_CR129","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-64503-x","volume":"16","author":"M Ohyagi","year":"2025","unstructured":"Ohyagi, M., Ito, M., Iizuka-Koga, M., Mise-Omata, S. & Yoshimura, A. Stage-specific roles of clonally expanded CD8+ T cells in regulating amyloid pathology in Alzheimer\u2019s disease models. Nat. Commun. 16, 9458 (2025).","journal-title":"Nat. Commun."},{"key":"2538_CR130","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.bbi.2020.05.070","volume":"89","author":"MS Unger","year":"2020","unstructured":"Unger, M. S. et al. CD8+ T-cells infiltrate Alzheimer\u2019s disease brains and regulate neuronal- and synapse-related gene expression in APP-PS1 transgenic mice. Brain Behav. Immun. 89, 67\u201386 (2020).","journal-title":"Brain Behav. Immun."},{"key":"2538_CR131","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1038\/s41593-024-01682-8","volume":"27","author":"S Kedia","year":"2024","unstructured":"Kedia, S. et al. T cell-mediated microglial activation triggers myelin pathology in a mouse model of amyloidosis. Nat. Neurosci. 27, 1468\u20131474 (2024).","journal-title":"Nat. Neurosci."},{"key":"2538_CR132","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41582-019-0244-7","volume":"15","author":"Y Hou","year":"2019","unstructured":"Hou, Y. et al. Ageing as a risk factor for neurodegenerative disease. Nat. Rev. Neurol. 15, 565\u2013581 (2019).","journal-title":"Nat. Rev. Neurol."},{"key":"2538_CR133","doi-asserted-by":"publisher","first-page":"15056","DOI":"10.1038\/nrdp.2015.56","volume":"1","author":"CL Masters","year":"2015","unstructured":"Masters, C. L. et al. Alzheimer\u2019s disease. Nat. Rev. Dis. Primers 1, 15056 (2015).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"2538_CR134","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41577-025-01238-2","volume":"26","author":"D Masopust","year":"2026","unstructured":"Masopust, D. et al. Guidelines for T cell nomenclature. Nat. Rev. Immunol. 26, 298\u2013313 (2026).","journal-title":"Nat. Rev. Immunol."},{"key":"2538_CR135","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/S1474-4422(11)70149-1","volume":"10","author":"L Kappos","year":"2011","unstructured":"Kappos, L. et al. Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring. Lancet Neurol. 10, 745\u2013758 (2011).","journal-title":"Lancet Neurol."},{"key":"2538_CR136","doi-asserted-by":"publisher","first-page":"6690","DOI":"10.3390\/jcm12206690","volume":"12","author":"R Harrington","year":"2023","unstructured":"Harrington, R., Harkins, P. & Conway, R. Janus kinase inhibitors in rheumatoid arthritis: an update on the efficacy and safety of tofacitinib, baricitinib and upadacitinib. J. Clin. Med. 12, 6690 (2023).","journal-title":"J. Clin. Med."},{"key":"2538_CR137","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1007\/s40265-017-0775-4","volume":"77","author":"HA Blair","year":"2017","unstructured":"Blair, H. A. & Deeks, E. D. Abatacept: a review in rheumatoid arthritis. Drugs 77, 1221\u20131233 (2017).","journal-title":"Drugs"},{"key":"2538_CR138","doi-asserted-by":"publisher","first-page":"104222","DOI":"10.1016\/j.cellimm.2020.104222","volume":"358","author":"A De Paula Pohl","year":"2020","unstructured":"De Paula Pohl, A. et al. Engineered regulatory T cells expressing myelin-specific chimeric antigen receptors suppress EAE progression. Cell. Immunol. 358, 104222 (2020).","journal-title":"Cell. Immunol."},{"key":"2538_CR139","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.omtm.2021.10.010","volume":"23","author":"M Arjomandnejad","year":"2021","unstructured":"Arjomandnejad, M. et al. Modulating immune responses to AAV by expanded polyclonal T-regs and capsid specific chimeric antigen receptor T-regulatory cells. Mol. Ther. Methods Clin. Dev. 23, 490\u2013506 (2021).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"2538_CR140","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.4049\/jimmunol.1200947","volume":"190","author":"TC Browne","year":"2013","unstructured":"Browne, T. C. et al. IFN-\u03b3 production by amyloid \u03b2-specific TH1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer\u2019s disease. J. Immunol. 190, 2241\u20132251 (2013).","journal-title":"J. Immunol."},{"key":"2538_CR141","doi-asserted-by":"publisher","first-page":"E1316","DOI":"10.1073\/pnas.1525466113","volume":"113","author":"SE Marsh","year":"2016","unstructured":"Marsh, S. E. et al. The adaptive immune system restrains Alzheimer\u2019s disease pathogenesis by modulating microglial function. Proc. Natl Acad. Sci. USA 113, E1316\u2013E1325 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"}],"container-title":["Nature Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41590-026-02538-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-026-02538-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-026-02538-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T15:02:25Z","timestamp":1782745345000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41590-026-02538-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":141,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["2538"],"URL":"https:\/\/doi.org\/10.1038\/s41590-026-02538-y","relation":{},"ISSN":["1529-2908","1529-2916"],"issn-type":[{"value":"1529-2908","type":"print"},{"value":"1529-2916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]},"assertion":[{"value":"19 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.M.H. co-founded, has equity in and is on the scientific advisory board of C2N Diagnostics. He is also on the scientific advisory board of Genentech, Denali Therapeutics and Switch Therapeutics and consults for Pfizer, Novartis and Roche. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}